CSF‐1R inhibition disrupts the dialog between leukaemia cells and macrophages and delays leukaemia progression
Open Access
- 10 October 2020
- journal article
- research article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 24 (22) , 13115-13128
Abstract
Research in the last few years has revealed that leukaemic cells can remodel the bone marrow niche into a permissive environment favouring leukaemic stem cell expansion. Tumour‐associated macrophages (TAMs) are prominent components of the tumour microenvironment and play an important role in the onset and progression of solid tumours. However, little is known about their role in the development of acute lymphoblastic leukaemia (ALL). Using a unique mouse model of T‐ALL induced by injection of EL4 T‐cell lymphoma cells to syngeneic C57BL/6 mice, we report herein that ALL leads to the invasion of leukaemia‐associated monocyte‐derived cells (LAMs) into the bone marrow and spleen of T‐ALL mice. Furthermore, we found that leukaemia cells could polarize bone marrow–derived macrophages (BMDMs) into LAMs. In turn, LAMs were able to protect leukaemia cells from drug‐induced apoptosis in vitro. Therapies targeted against the TAMs by inhibiting colony stimulating factor‐1 receptor (CSF‐1R) have emerged as a promising approach for cancer treatment. In this study, we demonstrate that CSF‐1R inhibition inhibits the viability of BMDMs, blocks LAMs polarization and reduces the abundance of LAMs in T‐ALL mice. In vivo, combination treatment of CSF‐1R inhibitor and vincristine (VCR) dramatically increased the survival of T‐ALL mice and delayed leukaemia progression compared with VCR monotherapy. Finally, these data reinforce the role of microenvironments in leukaemia and suggest that macrophages are a potential target for the development of novel therapeutic strategies in T‐ALL.Keywords
This publication has 38 references indexed in Scilit:
- The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular CarcinomaPLOS ONE, 2013
- Genetic Ablation of CD68 Results in Mice with Increased Bone and Dysfunctional OsteoclastsPLOS ONE, 2011
- RETRACTED: TLR signaling-mediated differential histone modification at IL-10 and IL-12 promoter region leads to functional impairments in tumor-associated macrophagesCarcinogenesis, 2011
- Dendritic Cell-Specific ICAM-3–Grabbing Nonintegrin Expression on M2-Polarized and Tumor-Associated Macrophages Is Macrophage-CSF Dependent and Enhanced by Tumor-Derived IL-6 and IL-10The Journal of Immunology, 2011
- Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigmNature Immunology, 2010
- Alternative Activation of Macrophages: Mechanism and FunctionsImmunity, 2010
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapyBlood, 2010
- The chemokine system in diverse forms of macrophage activation and polarizationTrends in Immunology, 2004
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004